)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Plus Therapeutics
Plus Therapeutics (PSTV) investor relations material
Plus Therapeutics Business update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business update summary22 Jan, 2026
Financial Update and Capital Position
Completed an oversubscribed $15 million offering, extending runway through 2027 and enabling growth initiatives.
Access to three ongoing grants supports clinical milestones and operations through 2027.
Current cash and grants are expected to fund all planned milestones, with CNSIDE business targeting break-even by 2027, though clinical programs will continue to use cash.
No immediate plans for a reverse stock split; focus remains on execution and generating positive catalysts.
Market Opportunity and Unmet Needs
Over 1 million U.S. patients are at risk of CNS metastases, with up to 30% of adult cancer patients developing CNS mets, representing a significant and growing market.
CNSide diagnostic platform targets a $6B U.S. market, with a projected 500,000 patients per year and a commercial relaunch planned for Q3 2025.
REYOBIQ radiotherapeutic addresses a $16B U.S. market, offering up to 20x radiation delivery versus standard of care and benefiting from FDA Fast Track and Orphan Designations.
Diagnostic and Therapeutic Innovation
CNSide offers a comprehensive, highly sensitive tumor cell capture and interrogation system, with 95% specificity and 92% sensitivity, and over 11,000 tests completed.
The platform provides four tests from a single sample, enabling diagnosis, treatment monitoring, and personalized therapy selection.
REYOBIQ is a first-in-class targeted radiotherapeutic with dual delivery modalities, capable of delivering up to 20x the radiation dose of standard care directly to CNS tumors.
CNSide Diagnostics offers proprietary CSF assays to improve management of leptomeningeal metastases.
Key considerations for REYOBIQ GBM pivotal design?
CNSide payor strategy to reach 150M lives?
REYOBIQ commercial manufacturing capacity readiness?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Plus Therapeutics earnings date
Q4 202512 Mar, 2026
Plus Therapeutics
Next Plus Therapeutics earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative therapies for rare cancers. The company leverages nanotechnology and targeted drug delivery platforms to design precision treatments, including radiotherapeutics for central nervous system cancers and other challenging oncological conditions. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage